dc.contributor.author | Santos, Renato X. | |
dc.contributor.author | Melis, Valeria | |
dc.contributor.author | Goatman, Elizabeth A. | |
dc.contributor.author | Leith, Michael | |
dc.contributor.author | Baddeley, Thomas C. | |
dc.contributor.author | Storey, John M.D. | |
dc.contributor.author | Riedel, Gernot | |
dc.contributor.author | Wischik, Claude M. | |
dc.contributor.author | Harrington, Charles R. | |
dc.date.accessioned | 2022-05-13T19:32:01Z | |
dc.date.available | 2022-05-13T19:32:01Z | |
dc.date.issued | 2022-04-07 | |
dc.identifier | 215465727 | |
dc.identifier | e4b16495-0732-4438-9767-0f0ac5d99340 | |
dc.identifier | 85128469782 | |
dc.identifier.citation | Santos , R X , Melis , V , Goatman , E A , Leith , M , Baddeley , T C , Storey , J M D , Riedel , G , Wischik , C M & Harrington , C R 2022 , ' HMTM-Mediated Enhancement of Brain Bioenergetics in a Mouse Tauopathy Model Is Blocked by Chronic Administration of Rivastigmine ' , Biomedicines , vol. 10 , no. 4 , 867 . https://doi.org/10.3390/biomedicines10040867 | en |
dc.identifier.other | ORCID: /0000-0003-3737-8296/work/113225253 | |
dc.identifier.other | ORCID: /0000-0002-5261-5467/work/113225819 | |
dc.identifier.uri | https://hdl.handle.net/2164/18559 | |
dc.description | Funding: This study was sponsored by WisTa Laboratories Ltd., Singapore. (grant PAR1577). | en |
dc.format.extent | 21 | |
dc.format.extent | 2037120 | |
dc.language.iso | eng | |
dc.relation.ispartof | Biomedicines | en |
dc.subject | Alzheimer’s disease | en |
dc.subject | bioenergetics | en |
dc.subject | HMTM | en |
dc.subject | hydromethylthionine | en |
dc.subject | lactate | en |
dc.subject | mitochondria | en |
dc.subject | rivastigmine | en |
dc.subject | tau aggregation inhibitor | en |
dc.subject | tauopathy | en |
dc.subject | R Medicine (General) | en |
dc.subject | Medicine (miscellaneous) | en |
dc.subject | General Biochemistry,Genetics and Molecular Biology | en |
dc.subject | Supplementary Information | en |
dc.subject.lcc | R1 | en |
dc.title | HMTM-Mediated Enhancement of Brain Bioenergetics in a Mouse Tauopathy Model Is Blocked by Chronic Administration of Rivastigmine | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Medical Sciences | en |
dc.contributor.institution | University of Aberdeen.Institute of Medical Sciences | en |
dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
dc.contributor.institution | University of Aberdeen.Chemistry | en |
dc.description.status | Peer reviewed | en |
dc.identifier.doi | 10.3390/biomedicines10040867 | |
dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85128469782&partnerID=8YFLogxK | en |